CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

Tissue velocity field and its divergence

January 7, 2021 | Duke Precision Genomics Collaboratory

How does a fish grow back scales?

How does a fish grow back scales it has lost to be the right size? Why don’t they just keep growing? The secret lies in waves of Erk activity.

Clair Engstrom

January 4, 2021 | Duke Research Blog

Claire Engstrom, a Student Researcher Working to Treat Duchenne’s Muscular Dystrophy by Optimizing CRISPR-cas9

Claire first got involved with on-campus research through her pre-orientation program, PSearch.

em cells have the potential to turn into any cell type, which makes them an incredibly powerful tool for disease modeling and regenerative medicine.

December 1, 2020

CRISPR Tagging Improves Accuracy Of Model Cells Grown From Stem Cells

A team of biomedical engineers at Duke University has created a new way to turn stem cells into a desired cell type by mastering the language of gene regulatory networks.